Journal
/
/
Important Endpoints and Proliferative Markers to Assess Small Intestinal Injury and Adaptation using a Mouse Model of Chemotherapy-Induced Mucositis
Journal JoVE
Recherche en cancérologie
Un abonnement à JoVE est nécessaire pour voir ce contenu.  Connectez-vous ou commencez votre essai gratuit.
Journal JoVE Recherche en cancérologie
Important Endpoints and Proliferative Markers to Assess Small Intestinal Injury and Adaptation using a Mouse Model of Chemotherapy-Induced Mucositis
DOI:

07:05 min

May 12, 2019

, ,

Chapitres

  • 00:04Titre
  • 00:325-Fluorouracil (5-FU) Mucositis Induction
  • 01:095-Bromo-2 -Deoxyuridine (BrdU) Quantification and Tissue Collectio
  • 02:42BrdU Immunoreactive Cell Area Measurement
  • 04:23Crypt Depth Measurement
  • 04:57Results: Representative Small Intestine Injury Recovery Assessment
  • 06:17Conclusion

Summary

Traduction automatique

Here, we present a protocol to establish important endpoints and proliferative markers of small intestinal injury and compensatory hyperproliferation using a model of chemotherapy-induced mucositis. We demonstrate the detection of proliferating cells using a cell cycle specific marker and using small intestinal weight, crypt depth, and villus height as endpoints.

Vidéos Connexes

Read Article